FDA Adverse Event Malfunction Summary report: N

ENDEAVOR RESOLUTE RX CORONARY STENT SYSTEM

MDR report key: 1202444 · Received October 8, 2008

Report

Report Number
2953200-2008-00899
Event Type
Malfunction
Date Received
October 8, 2008
Date of Event
August 22, 2008
Report Date
September 8, 2008
Manufacturer
MEDTRONIC CARDIOVSCULAR GALWAY
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
BE
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

RESULTS: PENDING CD EVALUATION. DISSECTION. CONCLUSIONS: PENDING CD EVALUATION. SECONDARY INTERVENTION.

Description of Event or Problem · 1

A 3.0 MM DIAMETER X 23 MM LENGTH ENDEAVOR RESOLUTE RX DRUG-ELUTING CORONARY STENT DELIVERY SYSTEM WAS INSERTED INTO A PATIENT, FOR THE TREATMENT OF A 100% STENOTIC MID LAD LESION. IT WAS REPORTED THAT THE PATIENT SUFFERED AN AMI (ST SEGMENT ELEVATION). A CORONARY ANGIOGRAPHY WAS CARRIED OUT ON THE SAME DAY AT, WHERE AN OCCLUSION OF THE MID LAD WAS OBSERVED. THROMBOSIS ASPIRATION WAS CARRIED OUT WITH A MEDTRONIC EXPORT XT CATHETER. AN ENDEAVOR RESOLUTE DRUG-ELUTING STENT WAS SUCCESSFULLY IMPLANTED AT 16 ATM FOR 30 SECONDS; RESULTS WERE A SMOOTH AND STRAIGHT ARTERY WALL. HOWEVER, A DISSECTION (WITH BLEEDING) OCCURRED AT THE MIDDLE OF THE STENT. A TRANS-THORACIC ECHO-DOPPLER WAS PERFORMED IN THE CATH LAB. NO PERICARDIAL LESION WAS OBSERVED. IN ORDER TO TREAT THE DISSECTION AND TO RESOLVE THE ISSUE, A LONG INFLATION (3 MIN, AT 6 ATM) WAS CARRIED OUT WITH A SPRINTER LEGEND 3.0 X 12MM DILATION BALLOON. RESULT WAS A GOOD OUTCOME, WITH NO PATIENT CONSEQUENCES. PLEASE NOTE THAT THIS DEVICE IS DISTRIBUTED OUTSIDE THE UNITED STATES; HOWEVER, IT IS SIMILAR TO THE UNITED STATES DISTRIBUTED PRODUCT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR RESOLUTE RX CORONARY STENT SYSTEM NIQ MEDTRONIC CARDIOVSCULAR GALWAY NA UNK

Patients

Seq Age Sex Outcome Treatment
1 UNK SYNTRON MEDICATION WAS STOPPED TO BE REPLACED BY| HEPARIN A FEW DAYS BEFORE INTERVENTION